Download the Safety Data Sheet for NAD+ (Nicotinamide Adenine Dinucleotide), supplied for qualified laboratory research and manufacturing applications.
Product Identification
Product name: NAD+
Chemical name: Nicotinamide Adenine Dinucleotide
CAS number: 53-84-9
Molecular formula: C21H27N7O14P2
Molecular weight: 663.4 g/mol
Catalog number: SUN-P056
Grade: Research Grade
About the NAD+ SDS
The NAD+ Safety Data Sheet provides information relating to product identification, safe handling, storage, exposure controls, personal protective equipment, accidental release measures, stability and other relevant safety considerations.
Users should review the complete SDS before receiving, handling, storing or disposing of this material. Laboratory personnel should also follow their institution’s chemical hygiene plan, risk assessment procedures and applicable local regulations.
Download NAD+ SDS
Use the button below to download the current English-language Safety Data Sheet for NAD+.
[Download NAD+ Safety Data Sheet]
Important Document Notice
Product characteristics and safety information may vary according to the exact material form, salt form, hydration state, manufacturing specification and batch supplied. Always verify the product name, catalog number, CAS number, revision date and supplier information shown in the SDS against the product received.
The batch-specific Certificate of Analysis should be reviewed separately for identity, purity and analytical results.
Research Use Only
This product is supplied for qualified laboratory research and manufacturing use only. It is not intended for human consumption, veterinary use, diagnostic use, clinical use or therapeutic applications.
Need Additional Documentation?
For a batch-specific Certificate of Analysis, specification sheet or additional technical documentation, please contact Sunone and provide the product name, catalog number and batch number.
View NAD+ Product Information
For available specifications, packaging details and product information, visit the NAD+ product page.
Leave a Reply